Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
L6H21
Cat. No.:
OB0425LY-314
Appearance:
Solid
Purity:
99.46%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
L6H21 is a highly active and specific myeloid differentiation 2 (MD-2) inhibitor that binds to MD-2 protein with a high affinity.
Synonyms:
18778-38-6; (E)-3-(2,3-Dimethoxyphenyl)-1-(4-methoxyphenyl)prop-2-en-1-one; 2,3,4'-Trimethoxychalcone; (2E)-3-(2,3-Dimethoxyphenyl)-1-(4-methoxyphenyl)prop-2-en-1-one
CAS No.:
24533-47-9
Compound CID:
5346378
Formula:
C18H18O4
Formula Weight:
298.34
Specification
Target:
TNF receptor; Interleukin related; Toll-like receptor (TLR); NF-κB; NOD-like receptor (NLR); Caspase; Apoptosis; Bcl-2 Family; Reactive oxygen species
Pathway:
Apoptosis; Immunology/Inflammation; NF-κB; Metabolic enzyme/Protease
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
L6H21 can be used in the study of alcoholic liver disease, metabolic disorders and neuroinflammation.
